Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07758634 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension

StatusRecruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
A Study of CTX340 in Participants with Uncontrolled Hypertension.
Trial Details
NCT Number NCT07758634
Lead Sponsor CRISPR Therapeutics AG
Conditions
(from sponsor)		 Hypertension
Related terms Hypertension
Enrollment 69 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov